2016 Platinum Sponsors

confabsm-e1396543572437 dpt emergent fed Print WellSpringlogonew

Gold Sponsors

abbvie catalent2 cpl Pfriser cook jhs Woodfield Pharmaceutical

Silver Sponsors

Chemic PCI_Icons_logo PharmaPackSol SGS

Bronze Sponsors

Advanced Analytical Capsugel citra coating EI halologo jones mikart RopackLogo Vetter Therapure

Attendee Registration Opens in April:
The $395 registration fee includes entrance to the exhibit hall, conference sessions, breakfast, lunch, the networking cocktail reception, and refreshment breaks!

Please check back for the 2017 Conference Agenda

2016 Conference Agenda
Thursday, September 22: Exhibit Hall Hours 10:00 a.m. – 4:00 p.m.
8:30-9:15         Breakfast – sponsored by Emergent BioSolutions
9:15-9:20         Opening remarks, Moderator Frank Chrzanowski
9:20-10:00       Economies of Capability vs. Economies of Scale: Advancing CMO Decisions, Peter Stevenson, Pfizer
10:00-11:15     Mid-morning break in exhibit hall – sponsored by AbbVie
11:20-12:00     Serialization CMO Onboarding: Governance, Process and Lessons Learned, Chris Hauck, Allergan; Dawn Wang, KPMG
12:00-1:30       Lunch – sponsored by Pfizer CentreOne
1:30-2:00         Investigator Insights: Preparing for and Successfully Facilitating an FDA Inspection, Liatte Krueger, FDA
2:00-2:30         The CMO Landscape: Trends Update, Jim Miller, Pharmsource
2:30-3:00         Sustainable Materials Management in the Pharma Supply Chain, Mathy Stanislaus, U.S. EPA
3:15-4:00         Break in exhibit hall – sponsored by Pharma Tech Industries
4:00-5:15         Cocktail Networking Reception – sponsored by WellSpring

Friday, September 23
7:30-8:30    Breakfast
8:30-9:00     Ensuring the Integrity of Your Data at CMOs, John Avellanet, Cerulean Associates
9:00-9:30    GDUFA: Present and Future Challenges, Terri Nataline, Lachman Consultants
9:30-10:00    Biopharmaceutical Contract Manufacturing Trends, William Downey, HighTech Business Decisions
10:00-10:15    Mid-morning break
10:15-10:45     Pharmaceutical Processes: Batch or Continuous? Reality, Myth and Imagination, Girish Malhotra, Epcot International
10:45-11:30     R&D Outsourcing Panel: Ellie Krasney, Pfizer; Robert McKean, Teva; Arindam Bose, AbiologicsB
11:30-11:45    Closing Remarks/Prize Giveaway, Moderator Frank Chrzanowski

2016 Conference Speakers included:
Peter Stevenson, vice president and general manager, portfolio management, Global Established Pharma (GEP) Division, Pfizer
Christopher Hauck, director, global serialization, Allergan
Dawn Wang, manager, KPMG Life Science Advisory
Liatte Krueger, consumer safety officer/investigator drug specialist, FDA
Jim Miller, founder and president, Pharmsource
Mathy Stanislaus, assistant administrator, Office of Land and Emergency Management (OLEM), EPA
John Avellanet, founder and principal, Cerulean Associates
Terri Nataline, principal consultant, Lachman Consultants
William Downey, president, HighTech Business Decisions
Girish Malhotra, president, Epcot International
Robert McKean, vice president, chemistry, manufacturing & controls (US), Teva Pharmaceuticals
Ellie Krasney, associate research fellow, Pfizer
Arindam Bose, partner, AbioligicsB